Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) have found that increased exposure to bright sunlight may be associated with a lower risk of type 2 diabetes and heart disease by lowering blood insulin and triglyceride levels.

The study, published in the Journal of Clinical Endocrinology & Metabolism, is the first to suggest that regular exposure to bright sunlight might improve glucose and fat metabolism.

A team of researchers led by Dr Costas Christodoulides and Professor Fredrik Karpe from the Radcliffe Department of Medicine examined data from local weather stations coupled with blood and body fat measurements from over 10,000 healthy middle-aged people from the Oxford Biobank and the Netherlands Epidemiology of Obesity studies – these are large-scale databases of health information from volunteers living in Oxfordshire, UK, and Leiden, Netherlands. The Oxford team worked closely with colleagues at the Leiden University Medical Centre in the Netherlands for this study.

Read more (Radcliffe Department of Medicine website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.